S. 934 · 115th Congress
FDA Reauthorization Act of 2017
- Stage
- Reported from committee
- Sponsor
- Lamar Alexander
- Introduced
- 2017-04-25
- Latest action
- 2017-05-11 · Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Subjects
Executive agency funding and structure
Administrative law and regulatory procedures
Congressional oversight
Government buildings, facilities, and property
Performance measurement
Public contracts and procurement
International organizations and cooperation
Government studies and investigations
Health
Health information and medical records
User charges and fees
Fraud offenses and financial crimes
Child health
Infectious and parasitic diseases
Medical research
Licensing and registrations
Cancer
Drug therapy
Medical tests and diagnostic methods
Department of Health and Human Services
Health technology, devices, supplies
Health personnel
Small business
Hearing, speech, and vision care
Government information and archives
Public-private cooperation
Prescription drugs
Marketing and advertising
Computers and information technology
Public participation and lobbying
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Manufacturing
Alternative treatments
Administrative remedies